1. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
   S.R. Sharpton et al, 2021, Cell Metabolism CrossRef
2. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
   Shaghayegh Khanmohammadi et al, 2022, Pharmacological Research CrossRef
3. Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma
   Florian Weber et al, 2023, International Journal of Molecular Sciences CrossRef
4. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
   Hedyeh Ebrahimi et al, 2018, Middle East Journal of Digestive Diseases CrossRef
5. Resveratrol ameliorates nutritional steatohepatitis through the mmu‑miR‑599/PXR pathway
   Lingbo Kong et al, 2022, International Journal of Molecular Medicine CrossRef